Shota Kusuhara
Kashiwa, 2778577, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A case of diffuse large B-cell lymphoma achieving complete remission with epcoritamab after pseudoprogression.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: August 30, 2026
Intratumoral hemorrhage from brain metastases following nivolumab therapy for malignant melanoma: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: January 30, 2025
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer.
Journal: Cancer treatment and research communications
Published: January 04, 2025
Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study.
Journal: Cancer chemotherapy and pharmacology
Published: June 29, 2023
The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.
Journal: Cancer medicine
Published: January 30, 2023
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study.
Journal: Japanese journal of clinical oncology
Published: July 03, 2022
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: November 26, 2021
Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis.
Journal: Anticancer research
Published: October 07, 2021
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.
Journal: Breast (Edinburgh, Scotland)
Published: February 10, 2021
Last Updated: 09/26/2026